Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies

Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page

  1. Check
    today
    Change Detected
    Summary
    The revision indicator on the page was updated from v3.5.3 to v3.5.4, indicating a newer version of the page's revision or template.
    Difference
    0.0%
    Check dated 2026-05-16T09:09:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The site’s page revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor platform/content-system update rather than a change to the underlying trial information.
    Difference
    0.0%
    Check dated 2026-04-24T13:47:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the site metadata.
    Difference
    0.0%
    Check dated 2026-04-17T11:38:50.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T20:31:03.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T19:09:44.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding lapse notice as well as Revision: v3.4.1 from the page.
    Difference
    0.2%
    Check dated 2026-02-11T06:16:13.000Z thumbnail image

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.